<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="9894" whole_study_id="9894" phs="000656" v="1" p="1" createDate="2013-08-06T11:51:08-05:00" modDate="2022-03-03T10:50:15-05:00" maxParentChildStudyModDate="2022-03-03T10:50:15-05:00" handle="InfluenzaVaccination_Plasmablast_Antibody" num_participants="28"><StudyInfo accession="phs000656.v1.p1" parentAccession="phs000656.v1.p1"><BioProject id="PRJNA216951" entrez_id="216951" type="bp_admin_access"/><BioProject id="PRJNA216953" entrez_id="216953" type="bp_data_submission"/><StudyNameEntrez>Plasmablast Trafficking and Antibody Response in Influenza Vaccination</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>trace</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>U19 AI057229</Funding></StudyInfo><Authority><ICs><IC id="5" name="NIAID" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="QUAKE.STEPHEN" aid="2" auth="eRA" login="QUAKE.STEPHEN" fname="Stephen" mname="R" lname="Quake" email="quake@stanford.edu"><Role>PI</Role><Organization>STANFORD UNIVERSITY</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2003273233" aid="1" auth="cit" login="vanpanhuiswg" fname="Willem" mname="Gijsbert" lname="Van Panhuis" email="wilbert.vanpanhuis@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>We thank Norma Neff, Ben Passarelli, and Gary Mantalas at the Stanford Stem Cell Genome Center for assistance with sequencing. We also thank Sally Mackey for coordinating clinical recruitment, Sue Swope and Michele Ugur for collecting samples, Xiaosong He for providing access to samples, and Holden Maecker, Jackie Bierre, and Ben Varasteh at the Stanford Human Immune Monitoring Core for sample banking. This research was supported by National Institutes of Health Grant U19 AI057229 (to S.R.Q.). The clinical project was supported by National
Institutes of Health/NCRR CTSA Award UL1 RR025744.</acknowledgement_statement><ic_specific_access_term>Data Access Request.
Requesters and Approved Users agree to notify the NIAID Data Access Committee of any unauthorized data sharing, breaches of data security, or inadvertent data releases that may compromise data confidentiality within 24 hours of when the incident is identified. As permitted by law, notifications should include the known information regarding the incident and a general description of the activities or process in place to fully define and remediate the situation. Within 3 business days of the NIAID Data Access Committee notification, the Requester, through the Approved User and the Institutional Signing Official, agree to submit to the NIAID Data Access Committee a more detailed written report including the date and nature of the event, actions taken or to be taken to remediate the issue(s), and plans or processes developed to prevent further problems, including specific information on timelines anticipated for action.

All notifications and written reports of data security incidents should be sent to:
NIAID Data Access Committee 
vdifrancesco@niaid.nih.gov

The NIAID, the NIH, or another entity designated by the NIH may, as permitted by law, also investigate any data security incident. Approved Users and their associates agree to support such investigations and provide information, within the limits of applicable local, state and federal laws and regulations. In addition, Requesters and Approved Users agree to work with the NIAID and the NIH to assure that plans and procedures developed to address identified problems are mutually acceptable consistent with applicable law.
</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="1064" CGType="cg_class_other" title="Immunology Research Use" name="IRU" dac_uid="65" dac_name="NIAID " irb-approval-required="No"><Use-Restriction>The data will only be used for immunology research purposes.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>